Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2013


Immunology: A Pathway Through the Maze

30 Apr 2013 - 01 May 2013 - University of Oxford



Bookmark and Share


Immunology is a rapidly developing subject with wide-ranging implications for the pharmaceutical, healthcare and biotechnology industries.

Common questions include, for example: How does the immune system defend the body against infection? What goes wrong when autoimmunity develops? How can undesirable responses be controlled?

Team leaders, R&D directors, and researchers at the bench all need to understand the latest developments in immunology and their implications for drug discovery and development as well as disease treatment. An understanding of the fundamental features of the immune system is essential not only for those who work in areas directly related to infection and immunity, but also for those working in the development of biopharmaceuticals, vaccines and antibody therapy, who wish to exploit the technological advances that have resulted from our increased insight into how the system functions.

As well as offering a path through the immunology maze, the course will emphasize the R&D opportunities for therapeutic intervention that arise from recent advances in immunology, for example the use of therapeutic antibodies and recombinant molecules as potential drug treatments. After the introductory session, each lecture will begin by covering the basic concepts of a particular area of immunology; these will then be developed in such a way that participants are rapidly brought an understanding of the most recent findings.

Oxford is a leading centre in the creative development and application of the theory and techniques of immunology in collaboration with industry. The presenters are leading scientists in their fields and use these techniques in their day-to-day research. They work in the Nuffield Department of Surgery at the University of Oxford.



Further information
Scientific News
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Switch Lets Salmonella Fight, Evade Immune System
Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
HIV Protein Manipulates Hundreds of Human Genes
Findings search for new or improved treatments for patients with AIDS.
Breaking the Brain’s Garbage Disposal
The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein.
Flesh-Eating Bacteria Work Together
Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!